Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0 — FDA record Z-0002-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 8, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0
Reason
The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does not indicate an alarm condition or respond. This issue leads to temporary cessation of flow of a medication or fluid, requiring immediate intervention by the clinician.
Classification
Class I
Recalling firm
Fresenius Kabi USA, LLC
Quantity
4 instances
Agency-reported status
Terminated
Source record identifier
Z-0002-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: 00811505030122 version 5.2.0

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Domestic distribution to NJ and WI.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Oct 12, 2022
Recall initiation date
Sep 8, 2022
Center classification date
Oct 6, 2022
Termination date
Sep 10, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records